Skip to main content
SpringerLink
Log in

MMP-1 and MMP-2 Expression in Uterine Leiomyosarcoma and Correlation With Different Clinicopathologic Parameters

  • Original Article
  • Published:
The Journal of the Society for Gynecologic Investigation: JSGI Aims and scope Submit manuscript

Abstract

Objective

Matrix metalloproteinases (MMPs) have been suggested to play an important role in tumor invasion and metastasis because they degrade a wide range of components of the extracellular matrix. In the present study, we analyzed the expression of MMP-1 and MMP-2 proteins in patients with uterine leiomyosarcoma.

Methods

MMP-1 and MMP-2 expression was investigated by immunohistochemistry from paraffinembedded issue sections in 21 patients with uterine leiomyosarcoma (LMS). The immunohistochemical findings were correlated with different clinicopathologic characteristics of the patients.

Results

MMP-1 was expressed in 86% and MMP-2 was expressed in 48% of uterine LMS. There was a statistically significant positive correlation between vascular space involvement and MMP-2 expression (P = .05) and between age and MMP-2 expression, with patients over 50 years old having significantly more frequent MMp-2-positive tumors than patients younger than 50 years (P = .006). The relationship between MMP-2 expression and tumor stage and recurrence disease did not reach statistical significance. A trend towards prolonged disease-free survival was observed in women with MMP-2-negative LMS compared with patients with MMP-2-positive LMS (P = .09). Furthermore, a univariate analysis revealed that early tumor stage (P = .0001), age at diagnosis less than 50 years (P = .02), and the absence of vascular space involvement (P = .04) were associated with longer overall survival.

Conclusion

The statistically significant positive correlation between MMp-2 expression and vascular space involvement as well as the prolonged disease-free survival rate in patients with MMP-2 negative uterine LMS suggest that MMP-2 plays and important role in tumor invasion and metastasis. Further clinical studies with larger numbers of cases need to be performed to verify these findings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Zaloudek CJ, Norris HJ. Mesenchymal tumors of the uterus. In: Kurman RJ, ed. Blaustein’s pathology of the female genital tract. New York: Springer-Verlag, 1994:849–914.

    Google Scholar 

  2. Evans HL, Chawla SP, Simpson C, Finn KP. Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors. Cancer 1988;62:2239–2247.

    Article  CAS  Google Scholar 

  3. Nordal RR, Kristensen GB, Kaern J, Stenwig AE, Pettersen EO, Trope CG. The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma. Acta Oncol 1995;34:797–802.

    Article  CAS  Google Scholar 

  4. Van Dinh T, Woodruff JO. Leiomyosarcoma of the uterus. Am J Obstet Gynecol 1982;144:817–823.

    Article  Google Scholar 

  5. Silverberg SG. Leiomyosarcoma of the uterus. A clinicopathologic study. Obstet Gynecol 1971;38:613–628.

    Article  CAS  Google Scholar 

  6. Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cell from programmed cell death. Cell 1991;67:1107–1115.

    Article  Google Scholar 

  7. Brummer O, Böhmer G, Hollwitz B, Flemming P, Petry K, Kühnle H. MMP-1 and MMP-2 in the cervix uteri in different steps of malignant transformation—an immunohistochemical study. Gynecol Oncol 2002;84:222–227.

    Article  CAS  Google Scholar 

  8. Cox G, O’Byrne KJ. Matrix metalloproteinases and cancer. Anticancer Res 2001;21:4207–4220.

    CAS  PubMed  Google Scholar 

  9. Huppertz B, Kerschanska S, Demir AY, Frank HG, Kaufmann P. Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta. Cell Tissue Res 1998;291:133–148.

    Article  CAS  Google Scholar 

  10. Bishof P, Haenggli L, Campana A. Gelatinase and oncofetal fibronectin expression is dependent on integrin expression on human cytotrophoblasts. Hum Reprod 1995;10:734–742.

    Article  Google Scholar 

  11. Stetler-Stevenson WG. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 1996;148:1345–1350.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Jones JL, Walker RA. Control of matrix metalloproteinase activity in cancer. J Pathol 1997;183:377–379.

    Article  CAS  Google Scholar 

  13. Kikkawa F, Nawa A, Shibata N, et al. The different stimulatory effect of normal tissues on the secretion of matrix metalloproteinases and their inhibitors by human ovarian cancer cells. Anticancer Res 1998;18:4323–4328.

    CAS  PubMed  Google Scholar 

  14. Vegh GL, Tuncer ZS, Fulop V, Genest DR, Mok SC, Berkowitz RS. Matrix metalloproteinases and their inhibitors in gestational trophoblastic disease and normal placenta. Gynecol Oncol 1999;75:248–253.

    Article  CAS  Google Scholar 

  15. Nouvo GJ, MacConnel PB, Simsir A, Valea F, French DL. Correlation of the in situ detection of polymerase chain reaction amplified metalloproteinase complentary DNAs and their inhibitors with prognosis in cervical carcinoma. Cancer Res 1995;55:267–275.

    Google Scholar 

  16. Sier CF, Merino MJ, San-Juan J, Liotta LA, Stetler-Stevenson WG. Immunohistochemical distribution of type IV collagenase in normal, bening and malignant breast tissue. Am J Pathol 1990;136:585–592.

    Google Scholar 

  17. Shima I, Sagaguri Y, Kusukawa J, et al. Production of matrix metalloproteinase -2 metalloproteinase-3 related to malignant behavior of esophageal carcinoma. A clinicopathologic study. Cancer 1992;70:2747–2753.

    Article  CAS  Google Scholar 

  18. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994;18(6):535–558.

    Article  CAS  Google Scholar 

  19. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.

    Article  Google Scholar 

  20. Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y, Seiki M. Activation of the precursor of gelatinase A/72kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT1-MMP) and with lymph node metastais. Int J Cancer 1995;64:355–359.

    Article  CAS  Google Scholar 

  21. Vaisanen A, Tuominen H, Kallioinen M, Turpeenniemi-Hujanen T. Matrix metalloproteinase-2 (72kD type IV collagenase) expression occurs in the early stage of huiman melanocytic tumor progression and may have prognostic value. J Pathol 1996;180:283–289.

    Article  CAS  Google Scholar 

  22. Djonov V, Cresto N, Aebersold DM, et al. Tumor cell specific expression of MMP-2 correlates with tumor vascularisation in breast cancer. Int J Cancer 2002;21(1):25–30.

    CAS  Google Scholar 

  23. Herbst H, Wage T, Milani S, et al. Tissue inhibitor of metalloproteinases-1 and-2 expression in rat and human liver fibrosis. Am J Pathol 1997;150:1647–1649.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Huthala P, Chow LT, Tryggvason K. Structure of human type IV collagenase gene. J Biol Chem 1990;265:11077–11082.

    Google Scholar 

  25. Tanimoto H, Shigemasa K, Sasaki M, et al. Differential expression of matrix metalloproteinase-7 in each component of uterine carcinosarcoma. Oncol Rep 2000;7(6):1209–1212.

    CAS  PubMed  Google Scholar 

  26. Liokumovich P, Goldberg I, Davidson B, et al. Expression of metalloproteinases endometrial stromal sarcoma: Immunohistochemical study using image analysis. J Clin Pathol 1999;52:198–202.

    Article  CAS  Google Scholar 

  27. Mayerhofer K, Obermair A, Windbichler G, et al. Leiomyosarcoma of the uterus: A clinicopathologic multicenter study of 71 cases. Gynecol Oncol 1999;74(2):196–201.

    Article  CAS  Google Scholar 

  28. Johnson MD, Kim HRC, Chesler L, Taso-Wu G, Bouck N, Polverini PJ. Inhibition of angiogenesis by tissue inhibitor of metalloproteinases. J Cell Physiol 1994;160:194–202.

    Article  CAS  Google Scholar 

  29. Vardi JR, Tovell HMM. Leiomyosarcoma of the uterus: Clinicopathologic study. Obstet Gynecol 1980;56:428–434.

    CAS  PubMed  Google Scholar 

  30. Stetler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 1990;9:289–303.

    Article  CAS  Google Scholar 

  31. Zucker S, Lysik RM, Zarrabi MH, Moll U. M(r) 92,000type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 1993;53:140–146.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Gynecology and Obstetrics, Anesthesiology, and Gynecopathology, University of Vienna Medical School, A-1090, Vienna, Währinger Gürtel 18-20, Austria

    B. Bodner-Adler MD, K. Bodner MD, O. Kimberger MD, K. Czerwenka MD, S. Leodolter MD & K. Mayerhofer MD

Authors
  1. B. Bodner-Adler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Bodner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. O. Kimberger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K. Czerwenka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Leodolter MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Mayerhofer MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Bodner-Adler MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bodner-Adler, B., Bodner, K., Kimberger, O. et al. MMP-1 and MMP-2 Expression in Uterine Leiomyosarcoma and Correlation With Different Clinicopathologic Parameters. Reprod. Sci. 10, 443–446 (2003). https://doi.org/10.1016/S1071-5576(03)00120-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1071-5576(03)00120-5

Key words

Search

Navigation